| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
| Do | Catheter Precision, Inc.: Flyte Partners With Christian Cowan for New York Fashion Week, Expanding Its Presence Across Global Luxury Brands | 1 | GlobeNewswire (USA) | ||
| 02.09. | Catheter Precision, Inc.: Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean | 151 | GlobeNewswire (Europe) | Landmark international milestone unlocks significant new markets and broadens Flyte's addressable aviation footprint beyond the United StatesNew capabilities connect Flyte's growing Florida network... ► Artikel lesen | |
| 27.08. | Catheter Precision, Inc.: Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany | 628 | GlobeNewswire (Europe) | Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business Johns Hopkins Hospital, a world-renowned academic... ► Artikel lesen | |
| 20.08. | Catheter Precision, Inc.: Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates | 1 | GlobeNewswire (USA) | ||
| 18.08. | Catheter Precision, Inc.: Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market | 1 | GlobeNewswire (USA) | ||
| 11.08. | Catheter Precision, Inc.: Flyte Partners with The Nucleus Network for Inaugural Flagship Founder & Investor Event | 2 | GlobeNewswire (USA) | ||
| 06.08. | Catheter Precision, Inc.: Flyte Achieves Record Revenues in July | 196 | GlobeNewswire (Europe) | July 2026 Revenue Increased 102% sequential July Over June to Approximately $640,000 Retail Platform, Strategic Partnerships and Influencer Marketing Fuel Accelerating Growth FORT MILL, S.C., Aug.... ► Artikel lesen | |
| 04.08. | Catheter Precision, Inc.: Flyte Partners with Volato AI to Become First Enterprise Customer, Accelerating Technology Strategy to Scale Regional Private Aviation | 269 | GlobeNewswire (Europe) | Enterprise Artificial Intelligence Deployment Expected to Enhance Customer Experience, Improve Operating Efficiency, and Increase Workforce Productivity Across Flight Operations Technology Strengthens... ► Artikel lesen | |
| 04.08. | Catheter Precision sichert sich 2,8 Millionen US-Dollar durch Privatplatzierung von Vorzugsaktien | 1 | Investing.com Deutsch | ||
| 31.07. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 29.07. | Catheter Precision, Inc.: Flyte Partners with LDV at The Maidstone to Elevate Luxury Travel to the Hamptons | 2 | GlobeNewswire (USA) | ||
| 22.07. | Econ Corp Services DBA Investorideas.com: Aviation Stocks Lift Off: Flyte (VTAK) Teams Up with Blade Urban Air Mobility | 593 | Newsfile | Delta, British Columbia--(Newsfile Corp. - July 22, 2026) - Investorideas.com, a trusted leader in publishing investing ideas for over 25 years issues a snapshot of recent news for aviation stocks... ► Artikel lesen | |
| 21.07. | Catheter Precision, Inc.: Flyte Partners with Blade to Expand Vision Jet Distribution | 234 | GlobeNewswire (Europe) | Flyte's Vision Jet Fleet to Be Featured on Blade Platform, Expanding Distribution across One of the Industry's Leading Air Mobility Networks Strategic Partnership Expected to Increase Aircraft Utilization... ► Artikel lesen | |
| 15.07. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.07. | Catheter Precision reports preliminary revenue of $1M for quarter ended June 30 | 7 | Seeking Alpha | ||
| 10.07. | Catheter Precision Plunges as Traders Unwind Gains from Recent News | 1 | Benzinga.com | ||
| 08.07. | Catheter Precision (VTAK) Stock Soars Nearly 27% After-Hours: Here's Why it is Trending | 7 | Benzinga.com | ||
| 07.07. | Catheter Precision, Inc.: Flyte Partners with LifeVac to Equip Every Vision Jet with Life-Saving Equipment | 1 | GlobeNewswire (USA) | ||
| 02.07. | Catheter Precision's Flyte unit reports $1M revenue in H1 2026 | 4 | Investing.com | ||
| 02.07. | Catheter Precision, Inc.: Flyte Announces Successful Launch of New Direct-to-Consumer Booking Platform | 1 | GlobeNewswire (USA) |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 45,320 | +0,75 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Fresenius mit einem Kursziel von 56 Euro auf "Buy" belassen. Analyst Graham Doyle hält die Sorgen um das US-Geschäft mit... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,330 | -0,13 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ECKERT & ZIEGLER | 12,390 | +0,08 % | Cyberangriff erschüttert Eckert&Ziegler: Lieferverzögerungen und Auswirkungen auf Kurs | ||
| TELADOC HEALTH | 5,292 | -0,30 % | Here's Why Teladoc's Integrated Care Business Deserves More Attention | ||
| BICO GROUP | 1,822 | +0,22 % | BICO Group AB: Publication of BICO Group AB: Interim Report Q2 2026 | Improved profitability and AI advancements
"In the quarter we had a continued solid momentum with growth in our bench top instruments and consumables businesses, while still experiencing challenges... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,086 | +0,70 % | Dr. Steven S. Sangha: Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc. | Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection... ► Artikel lesen | |
| CERENOME | 1,914 | -5,25 % | Cerenome, Inc.: Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment | Capital will support continued CNSide commercial scale-up and development Initial tranche of funding provided at closing with future tranches linked to milestones Forecasted cash runway now into 2028... ► Artikel lesen | |
| RESMED | 188,30 | +0,05 % | RESMED INC: Statement of changes in beneficial ownership | ||
| CARDINAL HEALTH | 204,10 | +0,89 % | Catheter Precision, Inc.: Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany | Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business Johns Hopkins Hospital, a world-renowned academic... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,060 | -4,63 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie! | Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte... ► Artikel lesen | |
| ZIMMER BIOMET | 79,34 | -1,59 % | Zimmer Biomet plant Abbau von bis zu 580 Jobs in Winterthur | Winterthur - Hiobsbotschaft für die Mitarbeitenden des US-Medizintechnikkonzerns Zimmer Biomet in Winterthur: Im Zuge einer Umstrukturierung der Produktion könnten am Standort bis zu 580 der 730 Stellen... ► Artikel lesen | |
| UNIDOC HEALTH | 0,053 | -3,64 % | Unidoc Health Corp: Unidoc Health has no material changes | ||
| TANDEM DIABETES | 15,800 | +6,76 % | Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now | ||
| CO-DIAGNOSTICS | 1,120 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen |